Health

#SFHZ2607943ADecree of 30 March 2026 on the 'Interception' Experiment: Cancer Prevention Pathway for High-Risk Individuals

🇫🇷France··Other·Medium Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This French decree officially authorizes a four-year experimental program called 'Interception' starting from its publication date in 2026. The program establishes a dedicated cancer prevention pathway specifically targeting individuals identified as being at high genetic or medical risk of developing cancer. It aims to test new organized screening, surveillance, and early-intervention protocols outside the standard national screening programs. The experiment is defined by a detailed 'cahier des charges' (specifications document) that sets the exact inclusion criteria, medical protocols, participating centers, and evaluation methods. The first patient inclusion triggers the four-year clock, after which results will inform potential nationwide scaling.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Authorizes the 'Interception' experimental cancer prevention pathway effective from publication date (31 March 2026)
  • Sets total experiment duration at exactly four years starting from the date the first patient is included
  • Targets individuals at high genetic or medical risk of cancer for enhanced surveillance and early intervention

+ 3 more changes with Pro

Obligations

What this law requires

high

Implement the 'Interception' cancer prevention pathway experiment in accordance with the detailed specifications document (cahier des charges) as defined in the decree

Participating medical centers and healthcare providers authorized to conduct the experiment
operational
high

Enroll and include patients in the 'Interception' experiment only according to the inclusion criteria specified in the cahier des charges

Participating medical centers and healthcare providers
operational
high

Begin the four-year experimental period from the date of first patient inclusion, not from the publication date of the decree

Participating medical centers and experiment administrators
operational
high

Execute only the medical protocols, screening procedures, and surveillance methods specified in the cahier des charges

Participating medical centers and healthcare providers
operational
medium

Conduct the experiment exclusively within the participating centers designated in the cahier des charges

Participating medical centers and healthcare providers
operational

Affected Parties

High-risk individuals for cancer (genetic/familial predisposition)French hospitals and cancer centers participating in the experiment+3 more…

Tags

cancer prevention,high-risk patients,medical experimentation